重新审视帕金森病的定义和分类:来自两个新兴生物框架的见解
Nikolai Gil D Reyes1,2, Azalea Tenerife Pajo3, Gerard Saranza4,5,6,7
1Edmond J. Safra Program in Parkinson's Disease, the Rossy Progressive Supranuclear Palsy Centre, and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, ON, Canada.
Journal of neural transmission (Vienna, Austria : 1996)
|September 4, 2025
概括
两个新的框架,SynNeurGe和神经α-Synuclein疾病综合分期系统 (NSD-ISS),旨在对帕金森症进行分类.
科学领域:
- 神经科学
- 遗传学
- 生物标志物研究
背景情况:
- 帕金森病 (PD) 是一种复杂的神经退行性疾病,其临床和遗传特征各异.
- 错误折叠的α-synuclein聚合物形成了勒维病理,是PD病变的核心原因.
- 生物标志物和遗传学的进步推动了基于生物学的PD分类和分期.
研究的目的:
- 审查和比较两种新兴的帕金森病分类和分期框架:SynNeurGe标准和NSD-ISS.
- 突出这些基于生物学的PD模型的范围,定义和应用的差异.
- 讨论完善和实施这些PD研究和临床实践的持续挑战.
主要方法:
- 对SynNeurGe标准的审查,包括同核病变,神经退行,遗传风险和临床状态.
- 对神经α-Synuclein疾病综合分期系统 (NSD-ISS) 的分析,重点关注分子标记物,多巴胺功能障碍和遗传.
- 对两个框架的原则,操作定义和实施策略进行比较评估.
主要成果:
- SynNeurGe 分类了整个疾病谱的PD亚型,承认了临床异质性.
- 通过使用特定的生物标志物和进展阶段,NSD-ISS定义了神经元α-synuclein疾病.
- 这两个框架旨在改善早期检测和PD研究,但在方法和范围上有很大的不同.
结论:
- 这些框架代表了对生物定义的帕金森病概念的重大转变.
- 在机械学理解,生物标志物标准化,遗传多样性和道德考虑方面仍然存在挑战.
- 持续改进,验证和公平实施对于这些基于生物的PD模型的成功至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
01:24Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
01:37Neural Regulation
39.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.8K
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:29Biological Causes of Schizophrenia
145
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
145
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
941
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
941